Tadashi Kato

发表

Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

G. Guyatt, Y. Okamoto, T. Furukawa, 2018, BMC Medicine.

Prediction of remission in pharmacotherapy of untreated major depression: development and validation of multivariable prediction models

T. Furukawa, H. Fujita, M. Inagaki, 2018, Psychological Medicine.

Can personalized treatment prediction improve the outcomes, compared with the group average approach, in a randomized trial? Developing and validating a multivariable prediction model in a pragmatic megatrial of acute treatment for major depression.

T. Furukawa, T. Akechi, T. Debray, 2020, Journal of affective disorders.

Why some depressive patients perform suicidal acts and others do not

T. Furukawa, N. Yonemoto, A. Tajika, 2019, Psychiatry and clinical neurosciences.

Predictors of hypomanic and/or manic switch among patients initially diagnosed with unipolar major depression during acute‐phase antidepressants treatment

T. Furukawa, N. Watanabe, Shiro Tanaka, 2019, Psychiatry and clinical neurosciences.

S0033291721000027jra 3371..3380

R. Kessler, N. Sampson, T. Furukawa, 2022 .

The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase

T. Furukawa, N. Yonemoto, N. Watanabe, 2012, Trials.

Whose depression deteriorates during acute phase antidepressant treatment?

T. Furukawa, N. Yonemoto, Y. Ogawa, 2019, Journal of affective disorders.

Brief multifamily Psychoeducation for family members of patients with chronic major depression: a randomized controlled trial

N. Watanabe, T. Furukawa, T. Akechi, 2018, BMC Psychiatry.

Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial

Toshi A Furukawa, Tadashi Kato, Masaru Horikoshi, 2017, Journal of medical Internet research.

An individualized treatment rule to optimize probability of remission by continuation, switching, or combining antidepressant medications after failing a first-line antidepressant in a two-stage randomized trial

R. Kessler, N. Sampson, T. Furukawa, 2021, Psychological Medicine.

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan

G. Guyatt, T. Furukawa, N. Yonemoto, 2015, Trials.

Predicting relapse in major depression after successful initial pharmacological treatment.

T. Furukawa, N. Watanabe, T. Akechi, 2019, Journal of affective disorders.

Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial

T. Furukawa, N. Yonemoto, H. Imai, 2017, Journal of Medical Internet Research.